This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProduction, part of CPhI worldwide
1-3 November 2022
Messe FrankfurtFrankfurt, Germany

Holger Richly
Head of Laboratory Biologicals Development / Molecular Biology at Boehringer Ingelheim Pharma GmbH & Co. KG


Holger Richly currently works as an Associate Director and Lab Head on the development of manufacturing CHO cell lines at Boehringer Ingelheim in Biberach. Besides, he contributes to several projects involving NGS technologies and molecular biology topics like expression vector optimization, (epi)genetic elements and targeted integration. Before, he was working as a research group leader on chromatin biology in the realms of DNA repair, Aging and Stem Cell Differentiation. Holger holds a PhD in Biology from the University of Munich (Germany).

Agenda Sessions

  • Bispecific Molecule Formats and Concepts for Cell Line Development


Speakers at this event